mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

NCT07400003 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

NCT05599516 ·Status: UNKNOWN ·Phase: PHASE3

Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus

NCT07304284 ·Status: RECRUITING ·Phase: PHASE3

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

NCT02314923 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

NCT02269423 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

NCT05911048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

NCT06335849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

NCT02370589 ·Status: COMPLETED ·Phase: PHASE1

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

NCT02374385 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

NCT05614245 ·Status: WITHDRAWN ·Phase: PHASE1

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

NCT00000767 ·Status: COMPLETED ·Phase: PHASE1

Experimental Vaccine for Prevention of Ebola Virus Infection

NCT00374309 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

NCT06680128 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

NCT06734832 ·Status: RECRUITING ·Phase: PHASE3

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

NCT05301504 ·Status: UNKNOWN ·Phase: PHASE1

Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults

NCT06444048 ·Status: COMPLETED ·Phase: PHASE1

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

NCT07311148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

NCT06409494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

NCT04072497 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

NCT05548439 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

NCT03314103 ·Status: COMPLETED ·Phase: PHASE3

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

NCT07326878 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

NCT06063057 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

NCT03274102 ·Status: COMPLETED ·Phase: PHASE4

A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

NCT07425821 ·Status: RECRUITING ·Phase: PHASE1